EUROPEAN SOCIETY FOR ORGAN TRANSPLANTATION

ESOT 2021 Recordings

 

Aug 29 - Sept 1, 2021 Milano
Close
N. Poster
Poster title
Applicant name
Status
  3-OP CRISPR-CAS9 HLA-DELETED GLOMERULAR ENDOTHELIAL CELLS AS A TOOL TO DETECT PATHOGENIC NON-HLA ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS Baptiste Lamarthée Received Received
  6-OP TERMINAL COMPLEMENT ACTIVATION MAY NOT CONTRIBUTE TO ORGAN DAMAGE IN ANTIBODY-MEDIATED REJECTION Gesa Tiller Received Received
  7-OP CD56DIM CD16BRIGHT NK CELLS DURING ANTIBODY-MEDIATED REJECTION DISPLAY INCREASED PROLIFERATION, ACTIVATION AND TYPE-1 INFLAMMATORY CYTOTOXIC PROFILES Elodie Bailly Received Received
  9-OP WATERLOW SCORE ON ADMISSION AND POST-SURGERY RISK OF PROLONGED LENGTH OF STAY, EMERGENCY READMISSION AND MORTALITY RISK Anna Brotherton Received Received
  10-OP FRAILTY AND KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS Evelien Quint Received Received
  11-OP ASSESSING RISK FACTORS OF NON-ADHERENCE AND POST-TRANSPLANT OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS Kateryna Maksyutynska Received Received
  12-OP IMPACT OF THE COVID-19 PANDEMIC ON DAILY LIVES, EMOTIONS AND BEHAVIOURS OF KIDNEY TRANSPLANT RECIPIENTS Regina Van Zanten Received Received
  13-OP SOCIAL DISTRESS AND HEALTH-RELATED QUALITY OF LIFE IN SOLID ORGAN TRANSPLANT RECIPIENTS Noor Al Kaabi Received Received
  14-OP RENAL TRANSPLANT OUTCOMES IN YOUNG ADULTS BEFORE AND AFTER THE INTRODUCTION OF A YOUNG ADULT SERVICE Laura Baines Received Received
  15-OP SUPPORTING TEENAGE AND YOUNG ADULT TRANSPLANT RECIPIENTS DURING COVID-19 PANDEMIC USING A SOCIAL MEDIA PATIENT GROUP Daley Cross Received Received
  16-OP SHORT- AND LONG-TERM PREGNANCY OUTCOMES AFTER ORTHOTOPIC LIVER TRANSPLANTATION IN THE NETHERLANDS Jildau Meinderts Received Received
  17-OP FATIGUE AMONG HEART RECIPIENTS- A BARRIER TO SELF-EFFICACY? Matilda Almgren Received Received
  18-OP SYMPTOM OCCURRENCE AND DISTRESS AFTER HEART TRANSPLANTATION - A NATIONWIDE CROSS-SECTIONAL COHORT STUDY. Marita Dalvindt Received Received
  19-OP RECOVERY AND SELF-EFFICACY AFTER HEART TRANSPLANTATION- IMPORTANT ASPECTS OF SELF-MANAGEMENT Matilda Almgren Received Received
  20-OP THE MEANING OF SURVIVING THREE YEARS AFTER A HEART TRANSPLANT - A TRANSITION FROM UNCERTAINTY TO ACCEPTANCE THROUGH ADAPTATION Anna Forsberg Received Received
  21-OP FATIGUE, SELF-EFFICACY AND RECOVERY 1-5 YEARS AFTER LUNG TRANSPLANTATION Annette Lennerling Received Received
  22-OP ADAPTATION AFTER LUNG TRANSPLANTATION UP TO THREE YEARS AFTER TRANSPLANTATION. Martina Lundmark Received Received
  25-OP DIFFERENT PATTERNS OF RECURRENCE AFTER LIVER RESECTION AND TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMORS Jorgelina Coppa Received Received
  26-OP LONG TERM OUTCOMES AFTER LIVER TRANSPLANTATION VERSUS RESECTION FOR MILAN-IN NEUROENDOCRINE TUMOR LIVER METASTASES Marianna Maspero Received Received
  27-OP UNRESECTABLE GASTROINTESTINAL STROMAL TUMOR (GIST) LIVER METASTASES AS A NEW INDICATION FOR LIVER TRANSPLANTATION. HAS ITS TIME ARRIVED? Felipe Alconchel Received Received
  31-OP EVOLUTION OF PATIENTS WITH DEVASTATING BRAIN INJURY ADMITTED IN INTENSIVE CARE UNIT FOR INTENSIVE CARE TO FACILITATE ORGAN DONATION Alicia Perez Received Received
  32-OP PERCEIVED AND VERIFIED CANCER HISTORY IN POTENTIAL SOLID ORGAN DONORS: AN AUSTRALIAN COHORT STUDY James Hedley Received Received
  34-OP THE ROLE OF THE SURGICAL CARE PRACTITIONER IN ORGAN RETRIEVAL: A SINGLE-CENTRE EXPERIENCE Francesco Abbadessa Received Received
  35-OP ASSESSMENT OF DONOR-RECIPIENT SIZE MISMATCH BASED ON BODY SURFACE AREA INDEX AND ITS IMPLICATIONS ON OUTCOMES OF DECEASED-DONOR LIVER TRANSPLANTS Ioannis D. Kostakis Received Received
  38-OP FACING THE CHALLENGE: TRANSPLANT ACCESS FOR THE HIGHEST SENSITIZED PATIENTS (CPRA=100%). THE SPANISH EXPERIENCE Maria O Valentin Received Received
  39-OP IMPACT OF INHIBITION OF PCSK-9 AMONG RENAL TRANSPLANT RECIPIENTS WITH HIGH CARDIOVASCULAR RISK Osama Gheith Received Received
  40-OP IMPACT OF FULL CORRECTION OF POST-TRANSPLANT ANEMIA ON CARDIOVASCULAR SYSTEM IN RENAL TRANSPLANT RECIPIENTS RECEIVING ESA: PROSPECTIVE RCT Ayman Maher Nagib Received Received
  41-OP IS ERYTHROCYTOSIS MORE FREQUENT AFTER SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION?: A SINGLE-CENTER EXPERIENCE Marina Reis Received Received
  42-OP COMPARING SURVIVAL OUTCOMES FOR KIDNEY TRANSPLANT RECIPIENTS WITH PRE-EXISTING DIABETES VERSUS THOSE WHO DEVELOP POST-TRANSPLANTATION DIABETES Azm Hussain Received Received
  43-OP OUTCOMES OF SODIUM–GLUCOSE COTRANSPORTER 2 INHIBITORS AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN KIDNEY TRANSPLANT RECIPIENTS WITH DIABETES Tarek Mahmoud Received Received
  44-OP HLA ALLELES CW12 AND DQ4 IN KIDNEY TRANSPLANT RECIPIENTS ARE INDEPENDENT RISK FACTORS FOR THE DEVELOPMENT OF POST-TRANSPLANTATION DIABETES Azm Hussain Received Received
  45-OP SEMAGLUTIDE IS A SAFE AND EFFECTIVE TREATMENT IN PATIENTS AFTER LIVER TRANSPLANTATION WITH POST-TRANSPLANT DIABETES MELLITUS Maarten Tushuizen Received Received
  46-OP DETERMINATS OF THE APPERANANCE OF POST TRANSPLANT DIABETES MELLITUS AFTER KINDEY TRASNAPLANTION Maria Smyrli Received Received
  47-OP AMPUTATION AND ULCERATION IN TYPE-1 DIABETIC PATIENTS UNDERGOING SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION: A SYSTEMATIC REVIEW Jineel Raythatha Received Received
  48-OP EVEROLIMUS, GLUCOSE METABOLISM, AND ANTI- VISCERAL OBESITY EFFECT IN KIDNEY TRANSPLANT CANDIDATES Mikiko Yoshikawa Received Received
  49-OP OUTCOMES OF LIVER TRANSPLANTS FOR NASH FROM A LARGE SINGLE INSTITUTIONAL COHORT Aamir Nawaz Received Received
  50-OP VARIATIONS IN TM6SF2 RS58542926, PCSK9 RS505151 AND PCSK7 RS2277287 WITH THE RISK OF HEPATIC STEATOSIS AFTER LIVER TRANSPLANTATION Ahad Eshraghian Received Received
  51-OP IMPACT OF ELECTIVE LIGATION OF A PATENT ARTERIOVENOUS FISTULA IN KIDNEY TRANSPLANT RECIPIENTS ON BLOOD PRESSURE AND SERUM LEVELS OF CARDIAC BIOMARKERS Gregoire Masson Received Received
  52-OP POSITIVE IMPACT OF KIDNEY TRANSPLANTATION ON OLFACTORY ABILITY: RESULTS OF A CROSS-SECTIONAL CASE CONTROL STUDY. Chiara Caletti Received Received
  53-OP IMPACT OF FCGR3A POLYMORPHISMS ON AMR OUTCOME AND IVIG RESPONSE IN KIDNEY TRANSPLANT RECIPIENTS Alice Koenig Received Received
  54-OP THE FCGR3A-158 V/V-GENOTYPE IS ASSOCIATED WITH DECREASED SURVIVAL OF RENAL ALLOGRAFTS WITH CHRONIC-ACTIVE ANTIBODY-MEDIATED REJECTION Nicolle Litjens Received Received
  55-OP PREFORMED T-CELL ALLOIMMUNITY AND HLA EPLET MISMATCH TO GUIDE IMMUNOSUPPRESSION MINIMIZATION WITH TACROLIMUS MONOTHERAPY IN KIDNEY TRANSPLANTATION. Maria Meneghini Received Received
  56-OP HLA EPITOPE MISMATCHES IN KIDNEY TRANSPLANT RECIPIENTS WITH HISTOLOGICAL ANTIBODY-MEDIATED REJECTION WITH AND WITHOUT HLA DONOR-SPECIFIC ANTIBODIES Laura Llinàs-Mallol Received Received
  57-OP UNSUPERVISED MACHINE LEARNING IDENTIFIES FAST AND SLOW MODULATION OF DSA DYNAMICS FOLLOWING HLA- INCOMPATIBLE TRANSPLANTATION – 5 YEAR OUTCOMES. Sunil Daga Received Received
  58-OP MYELOID-DERIVED SUPPRESSOR CELLS IN KIDNEY TRANSPLANT RECIPIENTS AND THE EFFECT OF MAINTENANCE IMMUNOTHERAPY Maria Iglesias Escudero Received Received
  59-OP CLINICAL VALUE OF THE USE OF COMPLETE HIGH RESOLUTION HLA TYPING FOR THE DEFINITION OF DNDSA AFTER KIDNEY TRANSPLANTATION Maria Meneghini Received Received
  60-OP DONOR-SPECIFIC ELISPOT ASSAY FOR PREDICTING ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS Suwasin Udomkarnjananun Received Received
  61-OP HLA AND NON-HLA ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS WITH A HISTOLOGICAL PICTURE OF ANTIBODY-MEDIATED REJECTION Laura Llinàs-Mallol Received Received
  62-OP DEVELOPMENT OF DE NOVO DONOR-SPECIFIC HLA ANTIBODIES AND ABMR IN RENAL TRANSPLANT PATIENTS DEPENDS ON CYP3A5 GENOTYPE Justa Friebus-Kardash Received Received
  63-OP EVOLUTION OF HUMORAL LESIONS ON CONTROL BIOPSY STRATIFIES THE RISK FOR RENAL GRAFT LOSS AFTER ANTIBODY-MEDIATED REJECTION TREATMENT Antonin Bouchet Received Received
  64-OP CHALLENGING EARLY CHRONIC-ACTIVE ANTIBODY-MEDIATED REJECTION AFTER SUCCESSFUL DESENSITIZATION FOR CDC-CROSSMATCH-POSITIVE KIDNEY TRANSPLANTION. Annelies De Weerd Received Received
  65-OP TEMRA CD8 T CELLS FROM KIDNEY TRANSPLANT RECIPIENTS EXHIBIT ENHANCED PURINERGIC P2X4 RECEPTOR-DEPENDENT PROINFLAMMATORY AND MIGRATORY RESPONSES Nicolas Degauque Received Received
  66-OP GRANZYME B POSITIVE B CELLS ENRICH REGULATORY T CELL COMPARTMENT AND INDUCE INHIBITION OF EFFECTOR CD4+ CD25- T CELL RESPONSE. Nicolas Sailliet Received Received
  67-OP THE IMPACT OF DONOR AND RECIPIENT SIZE IN PAEDIATRIC RENAL TRANSPLANTATION Ioannis D. Kostakis Received Received
  69-OP IMPACT OF VASCULAR ANOMALIES ON SURGICAL COMPLICATIONS AND OUTCOME IN PEDIATRIC KIDNEY TRANSPLANTATION: A RETROSPECTIVE SINGLE-CENTER ANALYSIS. Gionata Spagnoletti Received Received
  70-OP FINAL HEIGHT OF CHILDREN OVER 12 YEARS INITIATED ON A STEROID MINIMISATION IMMUNOSUPPRESSIVE REGIMEN FOLLOWING KIDNEY TRANSPLANTATION Demetria Theodorou Received Received
  73-OP STANDARDISATION OF IMMUNOSUPPRESSIVE AND ANTI-INFECTIVE DRUG REGIMENS IN UK PAEDIATRIC RENAL TRANSPLANTATION: THE HARMONISATION PROGRAMME Stephen D Marks Received Received
  74-OP KIDNEY TRANSPLANTED CHILDREN NOT RESPONDING TO ANTI-REJECTION TREATMENT: HOW TO IMPROVE THE OUTCOME Irene Alberici Received Received
  77-OP LUNG TRANSPLANT FOR PULMONARY FIBROSIS; SMALLER DONOR LUNGS IMPACT SURVIVAL Gillian Hardman Received Received
  81-OP DONOR LYMPHOCYTES IN PERIPHERAL BLOOD OF PATIENTS AFTER LUNG TRANSPLANTATION COMPRISE HIGH FREQUENCIES OF KIR-POSITIVE T AND NK CELL SUBSETS Jenny Kuehne Received Received
  86-OP MONITORING OF ANTIVIRAL IMMUNE RESPONSE AS AN INDICATOR OF IMMUNOSUPPRESSION INTENSITY AND OUTCOME AFTER KIDNEY TRANSPLANTATION: THE VIRENO STUDY Veronica Di Cristanziano Received Received
  87-OP LUMINAL ACTIVATION OF COMPLEMENT WITH APICAL DEPOSITION OF C3DG AND C5B-9 IN THE PROXIMAL TUBULES IN KIDNEY TRANSPLANT RECIPIENTS Gustaf Isaksson Received Received
  91-OP OBSERVATIONS ON 24-HOUR EX SITU NORMOTHERMIC LIVER PERFUSION Amelia Hessheimer Received Received
  95-OP ASSOCIATION OF PROCUREMENT TIME WITH SHORT- AND LONG-TERM OUTCOMES AFTER LIVER TRANSPLANTATION Verner Eerola Received Received
  96-OP HEPATITIS B OCCULT INFECTION IN DECEASED LIVER DONORS: LONG TERM POST TRANSPLANT CLINICAL EVALUATION. Davide Cussa Received Received
  97-OP PROPOSAL AND VALIDATION OF A LIVER GRAFT DISCARD SCORE FOR LIVER TRANSPLANTATION: A MULTICENTRE ITALIAN STUDY Fabio Melandro Received Received
  98-OP EXTENDED CRITERIA DONORS IN LIVER TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS Francesco Giovinazzo Received Received
  99-OP DONATION AFTER CIRCULATORY DEATH LIVERS CAN BE SAFELY USED FOR TRANSPLANTATION IN PATIENTS WITH PRE-EXISTING PORTAL VEIN THROMBOSIS Willemijn Van Der Plas Received Received
  100-OP RISK FACTORS ASSOCIATED WITH HISTOLOGICAL INJURY TO THE DEEP PERIBILIARY GLANDS AND PERIBILIARY VASCULAR PLEXUS PRIOR TO LIVER TRANSPLANTATION Willemijn Van Der Plas Received Received
  101-OP INDICATIONS AND WAITING LIST PRIORITY FOR DECEASED DONOR LIVER TRANSPLANTATION IN HIV/HCV CO-INFECTED PATIENTS IN JAPAN. Susumu Eguchi Received Received
  102-OP RECENT TRENDS AND INTENTION-TO-TREAT SURVIVAL OF LIVER TRANSPLANTATION FOR NONALCOHOLIC STEATOHEPATITIS:AN ITALIAN LIVER TRANSPLANT REGISTRY STUDY Chiara Di Renzo Received Received
  103-OP OUTCOMES OF DONORS WITH BMI=30 FOR LIVING DONOR LIVER TRANSPLANTATION Oya Andacoglu Received Received
  104-OP PERFORMANCE OF ARTIFICIAL INTELLIGENCE IN PREDICTING SURVIVAL FOLLOWING LIVER TRANSPLANTATION: STUDY USING DATA FROM THE KOREAN TRANSPLANT REGISTRY Young-Dong Yu Received Received
  105-OP UPDATE ON WAITLIST MORTALITY OF YOUNG PATIENTS WITH BILIARY ATRESIA - RESULTS FROM THE EUROTRANSPLANT DATABASE Heda Esmati Received Received
  106-OP LIVER TRANSPLANTATION (LT) IN HIGH-MELD (= 30) PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF): SINGLE-CENTER EXPERIENCE WITH 90 CASES Andrea Della Penna Received Received
  107-OP EVOLUTION OF INDICATION IN LIVER TRANSPLANTATION IN ITALY: THE CNT REGISTRY STUDY; ECALITA STUDY. ON BEHALF OF ECALITA STUDY GROUP Tommaso Maria Manzia Received Received
  108-OP IMPACT EXTENDED LIVING DONOR CRITERIA FOCUSING ON DONOR SAFETY IN LIVING DONOR LIVER TRANSPLANTATION Joodong Kim Received Received
  109-OP HLA-DQ DISPARITIES AND KIDNEY TRANSPLANT OUTCOME Aleksandar Senev Received Received
  110-OP KIDNEY RECIPIENTS CHARACTERISTICS QUESTIONED THE DISCRIMINATIVE CAPACITIES OF KIDNEY DONOR RISK INDEX: AN EXTERNAL VALIDATION FROM A FRENCH COHORT Anne-Hélène Querard Received Received
  111-OP DONOR FACTORS -FOR KIDNEYS ACCEPTED FOR TRANSPLANTATION- MARGINALLY IMPACT TRANSPLANT OUTCOMES. CONCLUSIONS FROM NATIONWIDE PAIRED OUTCOME ANALYSES Jan Lindeman Received Received
  112-OP IMPACT OF ASIAN AND BLACK DONOR AND RECIPIENT ETHNICITY ON THE OUTCOMES AFTER DECEASED DONOR KIDNEY TRANSPLANTATION IN THE UNITED KINGDOM Abdul Rahman Hakeem Received Received
  113-OP PREDICTING NUCLEAR RENOGRAPHY BASED SPLIT RENAL FUNCTION IN LIVING DONOR TRANSPLANTATION WITH CT BASED MEASURED SPLIT RENAL VOLUMES Bahattin Ozkul Received Received
  114-OP EPITOPE DISTRIBUTION AND FEASIBILITY OF PIRCHE-II T-CELL MATCHING FOR RENAL TRANSPLANTATION IN CANADA Karen R Sherwood Received Received
  115-OP ITALIAN NATIONAL KIDNEY ALLOCATION ALGORHITM (INKAA): APPLICATION AND FIRST RESULTS Andrea Ricci Received Received
  116-OP THE IMPACT OF COLD ISCHAEMIA TIME ON OUTCOMES OF LIVING DONOR KIDNEY TRANSPLANTATION IN THE UK LIVING KIDNEY SHARING SCHEME Stijn Van De Laar Received Received
  117-OP CLOSING THE GAP: EXAMINING WAIT LIST OUTCOMES FOR THE MOST HIGHLY SENSITIZED CANDIDATES IN THE USA ACROSS REGIONS Miriam Manook Received Received
  118-OP THE REMUZZI SCORE IS A SAFE DECISION-MAKING TOOL AND UTILIZES MORE KIDNEYS FOR TRANSPLANT COMPARED TO DONOR EGFR Annemarie Weissenbacher Received Received
  119-OP LONG-TERM EVOLUTION OF KIDNEY GRAFT DONATION PROCEDURES IN UNCONTROLLED DONORS AFTER CARDIAC DEATH IN THE COMMUNITY OF MADRID Alonso Mateos-Rodriguez Received Received
  120-OP MODIFIED FRAILITY INDEX (MFI-11): A SIMPLE TOOL TO ACCESS FRAILTY IN OLDER KIDNEY TRANSPLANT WAITING LIST POPULATION Mariana Sousa Received Received
  121-OP COMPARING OUTCOMES IN RIGHT VERSUS LEFT KIDNEY TRANSPLANTATION; A SYSTEMATIC REVIEW AND META-ANALYSIS Caitlin Carolan Received Received
  122-OP ARE UNSPECIFIED KIDNEY DONORS TREATED DIFFERENTLY TO SPECIFIED KIDNEY DONORS? VIEWS OF UK TRANSPLANT PROFESSIONALS Mira Zuchowski Received Received
  123-OP UK DECEASED DONATION AND TRANSPLANT ACTIVITY IN PAEDIATRICS FOR 2019 – 2020 Chloe Brown Received Received
  124-OP THE END STAGE RENAL DISEASE (ESRD) IN ANORECTAL MALFORMATION (ARM) PATIENTS: RISK FACTORS AND OUTCOME. Miriam Duci Received Received
  129-OP THE OUTCOME OF PLASMA CELL-RICH ACUTE REJECTION IN KIDNEY TRANSPLANTATION, IS IT REALLY POOR? Tarek Mahmoud Received Received
  131-OP HYPERACUTE HUMORAL NON-HLA ALLOGRAFT REJECTION AND PROTEIN S DEFICIENCY DISEASE, CASE REPORT AND REVIEW. Luis Garcia Covarrubias Received Received
  132-OP ALLOIMMUNE CELLULAR AND HUMORAL MONITORING IN A KIDNEY TRANSPLANT RECIPIENT THAT PRESENTS AN ACUTE LEUKEMIA TREATED WITH BLINATUMOMAB Paula Anton Pampols Received Received
  139-OP ORGAN DONATION IN KSA: COVID-19 PANDEMIC Besher Al-Attar Received Received
  141-OP IMPACT OF THE CHANGE IN ORGAN DONATION LAW IN ENGLAND ON DONATION RATES IN THE MULTICULTURAL AND ETHNICALLY DIVERSE CITY OF LONDON Lucy Dames Received Received
  142-OP OPT OUT LEGISLATION IN THE UK – PRELIMINARY DATA Sue Madden Received Received
  145-OP COMPUTERISED INTEGRATION OF ALTERNATIVE LIVING DONOR KIDNEY TRANSPLANTATION PROGRAMS: FIRST PROMISING RESULTS FOR DIFFICULT-TO-MATCH PATIENTS Marry De Klerk Received Received
  146-OP ALTRUISTIC KIDNEY DONATIONS: OPTIMIZING UTILITY AND BENEFICENCE Muhammad Yahya Jan Received Received
  149-OP BETA-CELL DEATH, RATHER THAN INSULIN RESISTANCE, DRIVES HYPERGLYCAEMIA IN ORGAN DONORS. Iestyn Shapey Received Received
  151-OP DIFFERENTIALLY METHYLATED CELL FREE DNA MONITORING IN PANCREAS TRANSPLANT RECIPIENTS WITH FUNCTIONING GRAFT Maria José Ramírez-Bajo Received Received
  153-OP UTILITY OF DONOR-DERIVED CELL-FREE DNA IN PANCREAS-KIDNEY TRANSPLANTATION Pedro Ventura-Aguiar Received Received
  154-OP EFFICACY AND SAFETY OF PANCREAS TRANSPLANT ALONE (PTA) IN SUBJECTS WITH TYPE 1 DIABETES (T1D): 15 YEAR ACTUAL FOLLOW-UP Walter Baronti Received Received
  170-OP MEDICATION ADHERENCE AND FEAR OF REJECTION AFTER CONVERSION FROM DUAL TO MONOTHERAPY: A RANDOMIZED CONTROLLED TRIAL Regina Van Zanten Received Received
  176-OP CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION Angela Carvalho-Gomes Received Received
  181-OP CXCR3+ CIRCULATORY FOLLICULAR HELPER T LYMPHOCYTES COULD HELP IN COVID-19 RESOLUTION IN KIDNEY TRANSPLANT RECIPIENTS Patricia Suàrez Fernández Received Received
  182-OP INCREASING DIAGNOSTIC ACCURACY IN RENAL TRANSPLANT PATIENT WITH ACUTE COVID-19 AND GRAFT FAILURE BY T CELL ANALYSIS IN PERIPHERAL BLOOD AND BIOPSY Ulrik Stervbo Received Received
  183-OP DETECTION OF PRE-EXISTING SARS-COV-2-REACTIVE T CELLS IN UNEXPOSED RENAL TRANSPLANT PATIENTS Arturo Blázquez Navarro Received Received
  184-OP COVID-19 SEVERITY INFLUENCES ANTI-SARS-COV2 ANTIBODIES TITER IN KIDNEY TRANSPLANT RECIPIENTS Francisco Gonçalves Received Received
  185-OP OUTCOMES OF KIDNEY TRANSPLANTATION AT THE EPICENTRE OF THE COVID-19 PANDEMIC: THE EXPERIENCE OF THE OSPEDALE MAGGIORE POLICLINICO Evaldo Favi Received Received
  186-OP IMPACT OF SARS-COV-2 INFECTION IN WAITING LIST FOR LIVER TRANSPLANTATION Anna Sessa Received Received
  187-OP LIVER TRANSPLANTATION IN PATIENTS WITH LIVER CIRRHOSIS RECOVERED FROM COVID-19 INFECTION Ahad Eshraghian Received Received
  188-OP SARS-COV-2 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS: ONE YEAR LATER. WHAT HAVE WE LEARNT? Joana Tavares Received Received
  189-OP LIVER TRANSPLANT RECIPIENTS WITH SARS-COV-2 INFECTION: RESULTS FROM AN ITALIAN MULTICENTER COHORT Chiara Mazzarelli Received Received
  190-OP COVID-19 MANAGEMENT IN PATIENTS AFTER HEART TRANSPLANTATION Maria Simonenko Received Received
  191-OP COVID-19 IN DECEASED RENAL TRANSPLANT RECIPIENTS Mariana Sousa Received Received
  192-OP EPIDEMIOLOGY AND CLINICAL RELEVANCE OF ACUTE KIDNEY INJURY IN COVID-19 KIDNEY TRANSPLANT RECIPIENTS Gabriele Guglielmetti Received Received
  193-OP INFLUENZA VACCINATION IN SOLID ORGAN TRANSPLANT RECIPIENTS: A NATIONWIDE POPULATION-BASED COHORT STUDY Susanne Dam Nielsen Received Received
  194-OP KIDNEY TRANSPLANT PATIENTS ARE ABLE TO GENERATE AND MOUNT VARICELLA ZOSTER-REACTIVE T CELL AND HUMORAL IMMUNITY FOLLOWING VARICELLA ZOSTER VACCINATION Toralf Roch Received Received
  195-OP CORRELATION BETWEEN COLD ISCHEMIA TIME AND THROMBOCYTOPENIA AFTER LIVER TRANSPLANTATION Marco Maria Pascale Received Received
  196-OP DANGER SIGNALS IN ORGAN PRESERVATION SOLUTION AFTER COLD ISCHEMIA IN LIVER TRANSPLANTATION: ACTIVATION OF MACROPHAGES AND ENDOTHELIAL CELLS Alberto Baroja-Mazo Received Received
  197-OP ROLE OF ACETYLCHOLINE IN LIVER GRAFTS FROM BRAIN DEAD DONORS WITH HEALTHY AND MARGINAL LIVERS WITH SIMPLE STEATOSIS OR NON-ALCOHOLIC STEATOHEPATITIS Marc Micó Carnero Received Received
  198-OP PERSISTENT BILIARY HYPOXIA AND LACK OF REGENERATION ARE KEY MECHANISMS IN THE PATHOGENESIS OF NON-ANASTOMOTIC STRICTURES AFTER LIVER TRANSPLANTATION Iris De Jong Received Received
  199-OP ANG-3777 TREATMENT ATTENUATES ISCHEMIA-REPERFUSION-INDUCED RENAL INJURY IN RAT AND DOG MODELS Prakash Narayan Received Received
  200-OP INFLUENCE OF THE ANESTHETIC METHOD ON THE OUTCOME OF A RODENT MODEL OF INTESTINAL ISCHEMIA-REPERFUSION INJURY Mathias Clarysse Received Received
  201-OP CLINICALLY APPLICABLE INTRALUMINAL PRESERVATION OF HUMAN SMALL BOWEL DOES NOT REDUCE HISTOLOGICAL DAMAGE COMPARED TO STANDARD VASCULAR FLUSH Anne Marye De Jong Received Received
  202-OP CALCIUM CARBONATE NANOPARTICLES IN AN EX VIVO RAT INTESTINAL PERFUSION MODEL: PREVENTION OF ISCHEMIC INJURY IN COLON AND SMALL INTESTINE Michele Finotti Received Received
  203-OP L-ARGININE PREVENTS ISCHEMIC INJURY IN EXPLANTED RAT INTESTINAL REGIONS IN AN EX VIVO PERFUSION MODE Michele Finotti Received Received
  204-OP ATTENUATION OF INTESTINAL ISCHEMIA-REPERFUSION INJURY IN A RODENT MODEL BY INTRAVENOUS ADMINISTRATION OF POLYETHYLENE GLYCOL Mathias Clarysse Received Received
  205-OP IN VIVO PHOSPHORYLATION OF C-MET BY ANG-3777, A HEPATOCYTE GROWTH FACTOR MIMETIC Latha Paka Received Received
  206-OP OXYGENATED VERSUS NON-OXYGENATED FLUSH OUT AND STORAGE OF DCD PORCINE LIVERS Isabel Brüggenwirth Received Received
  207-OP THE IRRADIATION-INDUCED RENAL ISCHEMIC PRECONDITIONING IS BLUNTED BY THE ORAL ADMINISTRATION OF THE ANTI-ANGIOGENIC AGENT, SUNITINIB Badr Khbouz Received Received
  208-OP ILOPROST INFUSION ACCELERATES THE RECOVERY OF RENAL FUNCTION IN PATIENTS EXPERIENCING IRI-RELATED DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANT Antonella Troiano Received Received
  209-OP IDENTIFICATION OF PREDICTIVE MARKERS FOR THE GENERATION OF WELL-DIFFERENTIATED IPSC-DERIVED KIDNEY ORGANOIDS Zhaoyu Du Received Received
  211-OP PORTAL VENOUS REPOPULATION OF DECELLULARISED RAT LIVER SCAFFOLDS WITH SYNGENEIC BONE MARROW STEM CELLS Mekhola Hoff Received Received
  220-OP DIFFERENTIALLY EXPRESSED TISSUE MICRORNAS DISTINGUISH SPECIFIC DISEASE PHENOTYPES FOLLOWING KIDNEY TRANSPLANTATION Špela Borštnar Received Received
  228-OP MAINTENANCE OF A DECEASED-DONOR KIDNEY TRANSPLANTATION PROGRAM DURING PANDEMIC SARS-COV-2 Richard Dumbill Received Received
  230-OP IS IT SAFE TO RECEIVE KIDNEYS FROM DECEASED KIDNEY DONORS WHO TESTED POSITIVE FOR COVID-19 INFECTION? Hatem Ali Received Received
  231-OP A NATIONAL RESPONSE TO COVID PRIORITISING LIVER TRANSPLANT RECIPIENTS WITH THE HIGHEST NEED PROVIDED EXCELLENT OUTCOMES IN THE UK Steven Masson Received Received
  235-OP ANASTOMOSIS TIME IS AN INDEPENDENT RISK FACTOR FOR PRIMARY GRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION: A RETROSPECTIVE COHORT STUDY Christelle M. Vandervelde Received Received
  236-OP FEASIBILITY OF SURVEILLANCE AFTER LUNG TRANSPLANTATION USING MULTIVOLUME MRI INSTEAD OF IONIZING RADIATION TECHNIQUES IN CYSTIC FIBROSIS PATIENTS Alessandro Palleschi Received Received
  237-OP CHRONIC KIDNEY DISEASE: A FREQUENT COMPLICATION IN PATIENTS WITH LUNG TRANSPLANT Marisa Serrano Salazar Received Received
  238-OP COMPARATIVE ANALYSIS OF SURVIVAL OF PATIENTS WITH CONGENITAL HEART DISEASE TRANSPLANTED FROM HEART OR HEART-LUNG Víctor Donoso Trenado Received Received
  239-OP CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN Raquel López-Vilella Received Received
  240-OP IS HEART TRANSPLANTATION A VALUABLE OPTION IN PATIENTS WITH SYSTEMIC RARE DISEASES? Concetta Di Nora Received Received
  241-OP SINGLE CENTER ASSESSMENT OF CARDIAC TRANSPLANTATION RESULTS COMPARING URGENT VERSUS ELECTIVE REGIMEN Mariafrancesca Fiorentino Received Received
  242-OP WAITLIST OUTCOMES AFTER THE IMPLEMENTATION OF A NEW ALLOCATION SYSTEM FOR URGENT HEART TRANSPLANTATION IN ITALY Alessandra Oliveti Received Received
  243-OP LIFE OF AN HEART FAILURE AND HEART TRANSPLANT CENTER IN THE COVID ERA : NEVER GIVE IN TO FEAR, USE TELEMEDICINE. Marco Masetti Received Received
  244-OP MYOCARDIAL SCAR BURDEN CORRELATES WITH CHANGES IN LEFT VENTRICULAR DIASTOLIC FUNCTION AND NT-PROBNP SERUM LEVELS IN HEART TRANSPLANT RECIPIENTS Gregor Poglajen Received Received
  245-OP DECREASED CIRCULATING CD34+ CELL COUNT IS ASSOCIATED WITH CORONARY ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS Gregor Poglajen Received Received
  246-OP MONITORING LYMPHOCYTE SUBPOPULATIONS IN PERIPHERAL BLOOD IN HEART TRANSPLANT RECIPIENTS. A NEW TOOL TO DETECT CAV? Clara Simón Ramón Received Received
  247-OP RISK FACTORS AND OUTCOMES OF ACUTE KIDNEY INJURY AFTER HEART TRANSPLANT Nicolina Conti Received Received
  248-OP THE RISK OF SKIN CANCER DOES NOT CORRELATE WITH VITAMIN D SERUM LEVELS IN HEART TRANSPLANT RECIPIENTS Neža Žorž Received Received
  249-OP MAGNETIC RESONANCE IMAGING TO ASSESS RENAL FLOW DISTRIBUTION DURING EX VIVO NORMOTHERMIC MACHINE PERFUSION Veerle A. Lantinga Received Received
  251-OP DONATION AFTER CIRCULATORY DEATH (DCD) STRATEGY IN ITALY: THE BARRIER OF A PROLONGED NO-TOUCH PERIOD CAN BE OVERCOME Lucia Masiero Received Received
  252-OP NORMOTHERMIC LIQUID VENTILATION ATTENUATES INFLAMMATION FROM ISCHEMIA-REPERFUSION INJURY IN AN EX VIVO RAT MODEL Helena M. Linge Received Received
  253-OP NORMOTHERMIC MACHINE PERFUSION FACILITATES DELIVERY OF RNA INTERFERENCE THERAPEUTICS IN DONOR KIDNEYS Emily Thompson Received Received
  254-OP TREATING CIRCULATORY DEATH DONOR KIDNEYS WITH ANTI-FIBROTIC DRUGS USING EX VIVO PRECISION CUT KIDNEY SLICES Leonie Van Leeuwen Received Received
  255-OP COMPLEMENT IS ACTIVATED DURING NORMOTHERMIC MACHINE PERFUSION OF PORCINE AND DISCARDED HUMAN KIDNEYS Leonie Venema Received Received
  256-OP NORMOTHERMIC REGIONAL PERFUSION VERSUS RAPID RECOVERY IN CONTROLLED DONATION AFTER CIRCULATORY DEATH KIDNEY TRANSPLANTATION Maria Padilla Received Received
  257-OP IMMUNE CELL PROFILING AND ASSESSMENT OF INFLAMMATORY CYTOKINE LEVELS IN THE PERFUSATE DURING NORMOTHERMIC MACHINE PERFUSION OF HUMAN LIVER ALLOGRAFTS Margot Fodor Received Received
  258-OP EXPLORING THE RELEASE OF EXTRACELLULAR VESICLES IN PERFUSATE AND BILE AS AN ADDITIONAL TOOL TO UNRAVEL MECHANISMS OF FUNCTION OF LIVER NMP. Nicholas Gilbo Received Received
  259-OP METABOLIC AND IMMUNOLOGICAL ALTERATIONS IN NORMOTHERMIC MACHINE PERFUSION OF THE LIVER AS COMPARED TO STATIC COLD STORAGE Maria Letizia Lo Faro Received Received
  261-OP MICROVASCULAR OBSTRUCTIONS IN PORTAL BILE DUCT CAPILLARIES AND HEPATIC SINUSOIDS DURING NORMOTHERMIC MACHINE PERFUSION OF MARGINAL HUMAN LIVERS Samuel Tingle Received Received
  262-OP RE-WRITING THE DEFINITION OF HIGH-RISK AND FUTILE DCD LIVER TRANSPLANTATION WITH NRP Ahmed E Sherif Received Received
  263-OP BENCH SURGERY AND KIDNEY AUTO-TRANSPLANTATION IN RESCUE OF GERM-CELL RESIDUAL MASS. 3D MODELS UTILITY IN SURGICAL PLANNING Victoria Gomez Received Received
  265-OP AN ALTERNATIVE WAY OF LAPAROSCOPIC PERITONEAL FENESTRATION BY USING A SECOND LAPAROSCOPE AND TRANSILLUMINATION TO MANAGE POST-TRANSPLANT LYMPHOCELES Vasileios Tatsis Received Received
  271-OP INEQUITABLE ACCESS TO TRANSPLANTS: PERSONS WITH IMPAIRED DECISION-MAKING CAPACITY Rebecca Thom Received Received
  272-OP FRIEND OR FOE: LAW, REGULATION AND THE PSYCHOSOCIAL ASSESSMENT OF LIVING KIDNEY DONORS Bonnie Venter Received Received
  273-OP FAMILY´S LEGAL ROLE IN DECEASED ORGAN PROCUREMENT. AN EUROPEAN AND COMPARATIVE LAW STUDY Marina Morla Received Received
  274-OP WITHDRAWING LIFE SUSTAINING TREATMENT AND ORGAN DONATION OF BRAIN DEATH PATIENTS Seungrye Jeong Received Received
  276-OP H2S ENRICHED FLUSH-OUT IN DBD AND NON-DBD PORCINE KIDNEYS Hanno Maassen Received Received
  281-OP CHARACTERISATION OF DISTINCT GRAFT INFILTRATES FOLLOWING REGULATORY T CELL THERAPY IN KIDNEY TRANSPLANT RECIPIENTS Matthew Brook Received Received
  283-OP INCIDENCE AND PREDICTORS OF FAILED KIDNEY ALLOGRAFT INTOLERANCE SYNDROME Carolina Ormonde Received Received
  284-OP LONG-TERM APHERESIS IN THE MANAGEMENT OF PATIENTS WITH RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS AFTER KIDNEY TRANSPLANTATION: A CASE SERIES Audrey Uffing Received Received
  285-OP TRANSPLANTECTOMY VERSUS NON-TRANSPLANTECTOMY AFTER FAILED KIDNEY TRANSPLANT. A SYSTEMATIC REVIEW AND META-ANALYSIS. Paschalis Gavriilidis Received Received
  286-OP ASSOCIATION BETWEEN DECEASED DONOR ACUTE KIDNEY INJURY ASSESSED BY BASELINE SERUM CREATININE BACK-ESTIMATION AND GRAFT SURVIVAL Rémi Lenain Received Received
  287-OP CLINICAL AND IMMUNOLOGICAL FOLLOW-UP OF VERY LONG-TERM KIDNEY TRANSPLANT RECIPIENTS TREATED WITH CALCINEURIN INHIBITORS Amaury Dujardin Received Received
  288-OP DEEP-LEARNING BASED PREDICTION OF CLINICAL ENDPOINTS IN RENAL PRE-IMPLANTATION BIOPSIES USING SLIDE-LEVEL LABELS Ka Ho Tam Received Received
  289-OP MOLECULAR AND CELLULAR MECHANISMS OF LIPOCALIN-2 MEDIATED RENOPROTECTION IN KIDNEY TRANSPLANTATION Anna Pfefferkorn Received Received
  290-OP REVISITING THE CHANGES IN THE BANFF CLASSIFICATION FOR ANTIBODY-MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION Jasper Callemeyn Received Received
  291-OP INTERSTITIAL FIBROSIS IN PREIMPLANTATION KIDNEY BIOPSIES OF EXTENDED CRITERIA DONORS PREDICTS LONG-TERM GRAFT SURVIVAL. Elisabetta Bussalino Received Received
  292-OP THREE-MONTH GRAFT FUNCTION OF KIDNEYS RETRIEVED 4.5 HOURS AFTER CIRCULATORY DEATH Deepti Antony Received Received
  293-OP ENDOTHELIAL TO MYOFIBROBLAST TRANSITION (ENMT) AND CAPILLARY VEGF LOSS ENHANCES THE DEVELOPMENT OF INTERSTITIAL FIBROSIS AND GLOMERULOSCLEROSIS Binnaz Handan Ozdemir Received Received
  294-OP AGGRAVATION OF FIBRIN DEPOSITION AND MICROTHROMBUS FORMATION WITHIN THE GRAFT DURING KIDNEY TRANSPLANTATION Tamar Van Den Berg Received Received
  295-OP HYPERLEPTINAEMIA AND LOW VALUES OF INTERLEUKIN 10 AS RISK FACTORS FOR GRAFT REJECTION IN PROTOCOL BIOPSY AFTER KIDNEY TRANSPLANTATION Ivana Dedinská Received Received
  296-OP POST-TRANSPLANTATION EARLY BLOOD TRANSFUSION AND KIDNEY ALLOGRAFT OUTCOMES: A SINGLE-CENTER OBSERVATIONAL STUDY Mehdi Maanaoui Received Received
  299-OP CORE SIGNATURE OF REJECTION-SPECIFIC CYTOKINES AND CHEMOKINES IN HEART BIOPSIES AFTER TRANSPLANTATION Lena Radomsky Received Received
  301-OP CARDIAC COMPUTED TOMOGRAPHY ANGIOGRAPHY FOR THE SCREENING OF CARDIAC ALLOGRAFT VASCULOPATHY, TWO YEARS OF EXPERIENCE Stefan Roest Received Received
  309-OP MALIGNANCIES BEFORE AND AFTER HEART TRANSPLANTATION – A SINGLE-CENTRE LONG-TERM OUTCOME STUDY Caroline Stenman Received Received
  310-OP CANCER TRANSMISSIONS AND NON-TRANSMISSIONS FROM SOLID ORGAN TRANSPLANTATION: AN AUSTRALIAN COHORT STUDY James Hedley Received Received
  311-OP SURVIVAL WITH TABELECLEUCEL IN PATIENTS WITH EPSTEIN-BARR VIRUS-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER SOLID ORGAN TRANSPLANT S Prockop Received Received
  312-OP DONOR-TRANSMITTED CANCERS: THE SPANISH EXPERIENCE Beatriz Dominguez-Gil Received Received
  313-OP SERIOUS ADVERSE EVENTS (SAE) AND SERIOUS ADVERSE REACTIONS (SAR) REPORTING IN GERMANY FROM 2016-2020: ANALYSIS OF DONOR-TRANSMITTED MALIGNANCY. Klaus Böhler Received Received
  314-OP HETEROGENEOUS INFLUENCE OF DIFFERENT FORMS OF POST-TRANSPLANT DE NOVO CANCER ON SURVIVAL OF KIDNEY GRAFTS – A COLLABORATIVE TRANSPLANT STUDY REPORT Christian Unterrainer Received Received
  315-OP POST-TRANSPLANT MALIGNANCIES AFTER PANCREAS TRANSPLANTATION: INCIDENCE AND IMPLICATIONS ON LONG-TERM OUTCOME FROM A SINGLE-CENTER PERSPECTIVE Felix Julius Krendl Received Received
  316-OP T AND B CELL ABUNDANCE ARE STRONGLY REDUCED IN THE IMMUNE MICROENVIRONMENT OF POST-TRANSPLANT MALIGNANCIES Simon Schran Received Received
  317-OP IMPACT OF CANCER ON THE RISK OF DEATH AMONG ITALIAN KIDNEY TRANSPLANT RECIPIENTS WITH A FUNCTIONING GRAFT: ITALIAN TRANSPLANT & CANCER COHORT STUDY Pierluca Piselli Received Received
  318-OP MANAGEMENT OF THE KIDNEY TRANSPLANT PATIENT WITH CANCER": REPORT FROM A CONSENSUS CONFERENCE. Gionata Spagnoletti Received Received
  319-OP RETROSPECTIVE STUDY OF NEOPLASM TRANSMISSION FROM ORGAN DONOR TO RECIPIENT Helena Martí Grífol Received Received
  320-OP POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN KIDNEY TRANSPLANT RECIPIENTS: A SINGLE CENTER STUDY Stathis Tsiakas Received Received
  321-OP DISTINCT IMPACT OF POSTTRANSPLANT MALIGNANCIES AND MORTALITY IN DIFFERENT IMMUNOSUPPRESSIVE THERAPY PROTOCOLS BASED- PERIODS IN A LONG-TERM FOLLOW-UP Ignacio Revuelta Received Received
  322-OP PREVALENCE AND CLINICAL SIGNIFICANCE OF PANCREATIC CYSTIC LESIONS IN IMMUNOSUPPRESSED PATIENTS WITH SOLID ORGAN TRANSPLANTATION Young-Dong Yu Received Received
  327-OP MTOR INHIBITORS PREVENT CMV INFECTION THROUGH THE RESTORATION OF FUNCTIONAL ?? AND G? T CELLS IN KIDNEY TRANSPLANTATION hannah kaminski Received Received
  331-OP MAXIMIZE THE USE OF ARTIFICIAL INTELLIGENCE IN ORGAN DONATION AND TRANSPLANTATION MANAGEMENT TO IMPROVE EFFICACY AND SAFETY Wenshi Jiang Received Received
  332-OP OUTPATIENT URETERIC STENT REMOVAL FROM KIDNEY TRANSPLANT RECIPIENTS USING ISIRIS IS FEASIBLE, SAFE AND COST-EFFECTIVE Fanourios Georgiades Received Received
  333-OP MULTILINEAR EGFR PROGRESSION PATTERN IS ASSOCIATED WITH GRAFT FAILURE IN KIDNEY TRANSPLANT RECIPIENTS Ruth Rahamimov Received Received
  334-OP PERSPECTIVES OF AUTOLOGOUS BLOOD TRANSFUSION AS A TOOL FOR PREVENTING IMMUNIZATION DURING NATIVE KIDNEY NEPHRECTOMY IN WAITING LIST CANDIDATES Alicja Debska-Slizien Received Received
  335-OP QUALITY OF LIFE AFTER LIVER TRANSPLANTATION, A CROSS-SECTIONAL SINGLE CENTRE STUDY. Mathias Vidgren Received Received
  336-OP QUALITY OF LIFE AND FATIGUE IN DE NOVO LIVER TRANSPLANT RECIPIENTS; 24-MONTH RESULTS FROM A MULTI-CENTER OPEN LABEL, RANDOMIZED CONTROLLED STUDY Midas Mulder Received Received
  337-OP COMPARING RENAL FUNCTION IN LT RECIPIENTS WITH LOW-DOSE TACROLIMUS AND SIROLIMUS VERSUS NORMAL-DOSE TACROLIMUS, A MULTICENTER RCT; 24-MONTH RESULTS Midas Mulder Received Received
  338-OP CLIF-C ACLF SCORE DOES NOT PREDICT SURVIVAL AFTER LIVER TRANSPLANTATION IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE Joris Blondeel Received Received
  339-OP LIVER TRANSPLANTATION IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE: A SINGLE CENTRE EXPERIENCE Joris Blondeel Received Received
  340-OP VARIOUS SELECTION CRITERIA FOR PRETRANSPLANT MYOSTEATOSIS AND THEIR VALUE IN THE ASSESSMENT OF SHORT- AND LONG-TERM OUTCOMES FOLLOWING OLT Zoltan Czigany Received Received
  341-OP ULTRA-LONG-TERM OUTCOME AND ITS DETERMINANTS AFTER LIVER TRANSPLANTATION IN ADULTS Laura Boer Received Received
  342-OP THERAPEUTIC ANTICOAGULATION IN PREVENTION OF RECURRENT PORTAL VEIN THROMBOSIS AFTER LIVER TRANSPLANTATION: UTILITY OR FUTILITY? Michel Rayar Received Received
  343-OP A PHOTOGRAPH OF PATIENTS APPROACHING LIVER TRANSPLANTATION: ASSESSMENT OF THE PSYCHOLOGICAL OUTCOME PREDICTORS Marco Valente Received Received
  344-OP AN ECONOMIC EVALUATION OF THE COST OF COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION IN THE UK NATIONAL HEALTH SYSTEM Dimitri A. Raptis Received Received
  346-OP VIEWS AND EXPERIENCES OF PATIENTS AWAITING A TRANSPLANT AND OF TRANSPLANTED PATIENTS: A NATIONAL SURVEY TO UNDERSTAND THEIR NEEDS Lia Bellis Received Received
  348-OP PSYCHOLOGICAL EVALUATION OF DIALYSIS PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS DURING COVID-19 Sanem Cimen Received Received
  352-OP BILIARY RECONSTRUCTION USING HIGH BILIARY RADICAL IS SAFE OPTION FOR MULTIPLE GRAFT BILE DUCT IN RIGHT LOBE LIVING DONOR LIVER TRANSPLANTATION JOODONG KIM Received Received
  353-OP RE-THINKING OF T-TUBE USE AT WHOLE LIVER TRANSPLANTATION: AN ANALYSIS ON THE RISK OF DELAYED GRAFT FUNCTION Riccardo Pravisani Received Received
  354-OP POST-LIVER TRANSPLANT INFERIOR VENA CAVA STENOSIS IN A LARGE VOLUME UK CENTRE. Fanourios Georgiades Received Received
  356-OP PHYSIOLOGICAL RECONSTRUCTIONS IN LIVER TRANSPLANTATION WITH NON-TUMORAL EXTENDED PORTAL VEIN THROMBOSIS: RESULTS AT TWO LARGE VOLUME CENTRES Domenico Pinelli Received Received
  357-OP EFFECT OF PRE-TRANSPLANT SARCOPENIA ON THE ESTIMATION OF STANDARD LIVER VOLUME IN LIVING-DONOR LIVER TRANSPLANT CANDIDATES Riccardo Pravisani Received Received
  358-OP A PROSPECTIVE ANALYSIS OF CLINICAL FRAILTY ASSESSMENT AND TELOMERE LENGTH IN A NATIONAL COHORT OF LIVER TRANSPLANT CANDIDATES Sinead Cremen Received Received
  359-OP FAST-TRACK LIVER TRANSPLANTATION: 100 MONTHS OF A FULL-FLEDGED ERAS PROTOCOL Gonzalo Rodríguez-Laiz Received Received
  360-OP ARE WE READY FOR BARIATRIC SURGERY IN A LIVER TRANSPLANT PROGRAM? A META-ANALYSIS Victor López-López Received Received
  369-OP OUTCOMES OF RABBIT ANTI-THYMOCYTE GLOBULIN VERSUS IL-2 RA INDUCTION THERAPIES IN 2DR MISMATCH RENAL TRANSPLANT RECIPIENTS Hatem Ali Received Received
  373-OP GRAFT UTILIZATION AFTER NORMOTHERMIC REGIONAL PERFUSION IN CONTROLLED DONATION AFTER CIRCULATORY DEATH - 5-YEAR EXPERIENCE FROM FRANCE Xavier Muller Received Received
  374-OP HYPOTHERMIC OXYGENATED MACHINE PERFUSION (HOPE) IN LIVER TRANSPLANTATION FOR EXPANDED CRITERIA DONOR GRAFT: SINGLE CENTER EXPERIENCE Luca Perin Received Received
  380-OP OPERATIONAL TOLERANCE-RELATED GENES ALLOW NON-INVASIVE DETECTION OF SUBCLINICAL REJECTION AT ONE YEAR AFTER RENAL TRANSPLANTATION Richard Danger Received Received
  382-OP AGE-RELATED PROTEOMIC DIFFERENCES IN DECEASED DONOR KIDNEYS ASSOCIATE WITH 12-MONTH POSTTRANSPLANTATION OUTCOME Philip Charles Received Received
  384-OP SUBOPTIMAL RECIPIENT OUTCOMES CORRELATE TO INCREASED INFLAMMATORY MARKERS IN DECEASED AFTER BRAIN DEATH DONORS Rebecca Vaughan Received Received
  387-OP THE EFFECT OF DONOR DIABETES-ASSOCIATED GENOTYPES ON OUTCOMES AFTER PANCREAS TRANSPLANTATION. Charles Sneddon Received Received
  388-OP PANCREAS TRANSPLANTATION FROM DONORS DECLARED DEATH BY CIRCULATORY CRITERIA: INITIAL EXPERIENCE IN SPAIN. Joana Ferrer Received Received
  389-OP METABOLIC OUTCOMES OF PANCREAS TRANSPLANT ALONE FROM DONATION AFTER CIRCULATORY DEATH DONORS - THE UK REGISTRY ANALYSIS Jeevan Gopal Received Received
  390-OP HUMAN AMNIOTIC EPITHELIAL CELLS PROTECT PANCREATIC ISLETS AGAINST PRO-INFLAMMATORY CYTOKINES Fanny Lebreton Received Received
  391-OP OUTCOMES OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTS FROM DONATION AFTER CIRCULATORY DEATH DONORS IN THE UK: A NATIONAL REGISTRY ANALYSIS Nikolaos Karydis Received Received
  392-OP DEVELOPMENT OF EX VIVO NORMOTHERMIC PERFUSION AS AN INNOVATIVE METHOD TO ASSESS PANCREASES AFTER PRESERVATION Ann Etohan Ogbemudia Received Received
  393-OP THE EUROPEAN P-PASS AND US PDRI SCORES ARE ASSOCIATED WITH INCREASED RISK OF PANCREAS GRAFT REJECTION Ky-Leigh Ang Received Received
  394-OP IMPROVED PANCREATIC GRAFTS SURVIVAL WITH OPERATING PROTOCOL AMENDMENTS. Pawel Skrzypek Received Received
  395-OP POST-TRANSPLANT INFLAMMATION IS LOCALISED TO THE PANCREAS GRAFT AND ASSOCIATED WITH EARLY GRAFT THROMBOSIS Kristina Rydenfelt Received Received
  396-OP COMPARISON OF DRB1 AND DQB1 ALLELE FREQUENCIES AND PRE-TRANSPLANT ANTI-HLA ANTIBODIES IN PATIENTS WAITING FOR PANCREAS VS. KIDNEY TRANSPLANT Fabio Vistoli Received Received
  397-OP TEN YEARS OF SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATIONS - SINGLE CENTRE NATIONWIDE EXPERIENCE Kaisa Ahopelto Received Received
  398-OP PANCREAS GRAFT SALVAGE AFTER DUODENAL LEAK - FOLEY OR FOLLY? OUTCOMES FROM OVER 1000 PANCREAS TRANSPLANTS Fungai Dengu Received Received
  399-OP FIRST POSTOPERATIVE DAY PLASMA AMYLASE CAN BE USED TO DETECT PATIENTS AT RISK OF COMPLICATIONS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION Akseli Bonsdorff Received Received
  400-OP ISLETS LOADED IN HYDROGEL DERIVED FROM HUMAN AMNIOTIC MEMBRANE REVERSE DIABETES IN IMMUNODEFICIENT MICE Kevin Bellofatto Received Received
  401-OP BLOCKADE OF THE IL-21 PATHWAY: A NEW PERSPECTIVE FOR THE TREATMENT OF T AND B CELL MEDIATED ALLOGENEIC RESPONSES AFTER TRANSPLANTATION Carla Baan Received Received
  402-OP PROLIFERATION OF CO-STIMULATION BLOCKADE RESISTANT-T CELLS REQUIRED EARLY IFN? PATHWAY ACTIVATION Florence Herr Received Received
  403-OP DETERMINING THE T CELLRECEPTOR REPERTOIRE IN DIRECT PEPTIDE-MHC ALLORECOGNITION BY CD8+ T CELLS Alexandra Sharland Received Received
  404-OP INCREASED FREQUENCY OF T CELL-MEDIATED REJECTION ASSOCIATED WITH ANTIBODY MEDIATED REJECTION IN HLA-DSA NEGATIVE TRANSPLANT RECIPIENTS David Rodriguez Fuentes. Received Received
  405-OP DO NOT BLAME THE INNOCENT: G?T CELLS ARE NOT INVOLVED IN DONOR SPECIFIC ANTIBODY GENERATION AFTER SOLID ORGAN TRANSPLANTATION Xavier Charmetant Received Received
  406-OP IMMUNOLOGICAL BEHAVIOR OF EARLY GRAFT INFILTRATING CELLS UNTIL 3 DAYS AFTER MURINE SKIN TRANSPLANTATION Ryo Kanazawa Received Received
  407-OP GENOME-WIDE MISMATCH AND DELETION ANALYSIS IN KIDNEY TRANSPLANTATION Salla Markkinen Received Received
  408-OP DONOR-RECIPIENT GENETIC MISMATCH IS ASSOCIATED WITH LIVER ALLOGRAFT REJECTION Lianne Nieuwenhuis Received Received
  409-OP SOLVENT ACCESSIBLE AMINO ACID MISMATCHES CALCULATED BY HLA-EMMA AS INDEPENDENT RISK FACTOR FOR DEATH-CENSORED GRAFT FAILURE IN RENAL TRANSPLANTATION Suzanne Bezstarosti Received Received
  410-OP LIVING DONOR KIDNEY TRANSPLANTATION IN PATIENTS WITH DONOR-SPECIFIC HLA ANTIBODIES AFTER DESENSITIZATION WITH IMMUNOADSORPTION Florian Kälble Received Received
  411-OP ANTI-THYMOCYTE GLOBULIN MEDIATED B-CELL ACTIVATION Moritz Muckenhuber Received Received
  412-OP MESENCHYMAL STROMAL CELL DERIVED MEMBRANE PARTICLES ARE INTERNALIZED BY MACROPHAGES AND ENDOTHELIAL CELLS AND EXHIBIT IMMUNOMODULATORY EFFECTS Martin Hoogduijn Received Received
  413-OP DELINEATING THE IMMUNOGENICITY OF GRAFT COMPONENTS IN COMPOSITE TISSUE ALLOTRANSPLANTATION Barbara Kern Received Received
  414-OP LOCAL IMMUNOSUPPRESSION IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION: PAVING THE WAY FOR A SAFER ALTERNATIVE Isabel Arenas Hoyos Received Received
  416-OP HEPATOPORTOENTEROSTOMY VERSUS PRIMARY LIVER TRANSPLANTATION FOR BILIARY ATRESIA Dor Yoeli Received Received
  417-OP THE ROLE OF VASCULAR ADHESION PROTEIN-1 IN THE PATHOGENESIS OF CHRONIC ALLOGRAFT HEPATITIS AFTER PAEDIATRIC LIVER TRANSPLANTATION Steffen Hartleif Received Received
  418-OP VEIN OUTFLOW OBSTRUCTION AFTER LEFT LATERAL SEGMENTS TRANSPLANT: EXPERIENCE AT A LARGE PEDIATRIC TRANSPLANTATION CENTER. Domenico Pinelli Received Received
  419-OP LIVER TRANSPLANTATION FOR LANGERHANS CELL HISTIOCYTOSIS : A PROTOCOL BASED APPROACH Jagadeesh Menon Received Received
  421-OP KIDNEY TRANSPLANTATION IN THE TRANSGENDER PATIENT- A CHALLENGE FOR CARE Irena Milaniak Received Received
  422-OP FIRST PERSON CONSENT: CHALLENGES TO APPROACHING FOR DONATION. Bethany Hall Received Received
  424-OP COLLABORATIVE WORKING- KEY TO MAINTAINING NORMAL ORGAN DONATION AND TRANSPLANT SERVICE DURING COVID PANDEMIC IN NORTHERN IRELAND Mary Hayes Received Received
  431-OP SYSTEMATIC SCREENING FOR SARS-COV-2 S1/S2 ANTIBODIES HELPS TO BETTER ASSESS THE REAL INCIDENCE OF COVID-19 IN KIDNEY TRANSPLANT RECIPIENTS Louis Firket Received Received
  436-OP THE DONOR ACTION PROGRAM IN THE EMILIA-ROMAGNA REGION FROM 1998 TO 2019: RESULTS Carlo De Cillia Received Received
  437-OP ORGAN DONATION AND TRANSPLANT IN THE ENGLISH-SPEAKING CARIBBEAN REGION: 10 YEARS OF INTERNATIONAL COOPERATION Maria Gomez Received Received
  438-OP QUALITY MANAGEMENT SYSTEM APPLIED TO ORGAN DONATION: UNITED ARAB EMIRATES EXPERIENCE Maria Gomez Received Received
  439-OP SOLUBLE UROKINASE RECEPTOR AND MORTALITY IN KIDNEY TRANSPLANT RECIPIENTS Christian Morath Received Received
  440-OP COMPARATIVE TRANSCRIPTOME ANALYSIS REVEALS A POTENTIAL ROLE OF C1QB IN CHRONIC ANTIBODY-MEDIATED REJECTION OF KIDNEY ALLOGRAFS. Mattia Rossi Received Received
  441-OP VALIDATION OF FLAVIN MONONUCLEOTIDE TO MONITOR QUALITY OF DONOR KIDNEYS DURING HYPOTHERMIC (OXYGENATED) MACHINE PERFUSION IN KIDNEY TRANSPLANTATION Fenna Van De Leemkolk Received Received
  442-OP MONITORING OF MOLECULAR PROFILING OF REGULATORY T CELL BIOMARKERS BY USING NON-INVASIVE STRATEGIES TO PREDICT OUTCOME IN RENAL TRANSPLANTATION. Angelica Canossi Received Received
  443-OP URINARY EXTRACELLULAR VESICLES AND VESICULAR CELL-FREE DNA AS POTENTIAL BIOMARKERS FOR KIDNEY ALLOGRAFT INJURY Ivana Sedej Received Received
  444-OP NUCLEAR FACTOR OF ACTIVATED T CELLS AS POTENTIAL PHARMACODYNAMIC BIOMARKER FOR THE RISK OF ACUTE AND SUBCLINICAL REJECTION IN LIVER RECIPIENTS Olga Millan Received Received
  445-OP CONNECTION OF BANK1, TOLERANCE, REGULATORY B CELLS, AND APOPTOSIS: PERSPECTIVES OF A REDUCTIONIST INVESTIGATION. Ludmilla Le Berre Received Received
  446-OP IMPACT OF STEATOSIS AND COLD ISCHEMIA TIME ON MITOCHONDRIAL RESPIRATION IN HUMAN LIVER ALLOGRAFTS Andras T. Meszaros Received Received
  447-OP APPLICATION OF THIN-FILM SOLID-PHASE MICROEXTRACTION TO BILE ANALYSIS - BILE FINGERPRINT AS A PROGNOSTIC MARKER DURING LIVER TRANSPLANTATION Kamil Luczykowski Received Received
  448-OP VIABILITY ASSESSMENT USING THE "SIX GENE SIGNATURE" DURING LIVER PERFUSION Rodrigo Figuerido Received Received
  449-OP ADVANTAGES OF PLASMATIC CXCL10 AS A PROGNOSTIC & DIAGNOSTIC BIOMARKER FOR THE RISK OF REJECTION AND SUBCLINICAL REJECTION IN KIDNEY TRANSPLANTATION. Olga Millan Received Received
  450-OP MONITORING KIDNEY GRAFT INJURY BY MEASURING DONOR-DERIVED CELL FREE DNA (DD-CFDNA) Emilio Rodrigo Received Received
  451-OP HUMAN CD81 EXTRACELLULAR VESICLES ARE RELEASED DURING NORMOTHERMIC MACHINE PERFUSION Wouter Woud Received Received
  452-OP TRANSFORMING GROWTH FACTOR-?1 EXPRESSION IN RENAL TRANSPLANT URETER TISSUE AND POST-TRANSPLANT URETERAL STRICTURE Emmy Hartog Received Received
  455-OP SODIUM/GLUCOSE COTRANSPORTER 2 INHIBITORS IN RENAL TRANSPLANT DIABETIC PATIENTS. SINGLE CENTER PILOT STUDY. Claudia Muñoz Martínez Received Received
  462-OP LUNG TRANSPLANT RECIPIENTS DEVELOPING EARLY DSA WITHIN THE FIRST MONTH EXHIBIT A HIGHER FREQUENCY OF NAÏVE AND A LOWER FREQUENCY OF MEMORY B CELLS Stella Christoph Received Received
  464-OP PARTICLE FLOW RATE FROM THE AIRWAYS AS A MARKER FOR CHRONIC LUNG ALLOGRAFT DYSFUNCTION (CLAD) Embla Bodén Received Received
  466-OP KAPOSI´S SARCOMA (KS) IN PEDIATRIC LIVER TRANSPLANTATION (LT) – 3 CLINICAL CASES Catarina Cordeiro Received Received
  469-OP LONG TERM SURVIVAL AFTER CHORIOCARCINOMA TRANSMITTED BY LIVER GRAFT: A SUCCESSFUL REPORT IN PAEDIATRIC TRANSPLANTATION Inês Pessanha Received Received
  479-OP CIRCULATORY FOLLICULAR HELPER T LYMPHOCYTES PROTECT AGAINST CMV INFECTION IN KIDNEY TRANSPLANT RECIPIENTS Patricia Suàrez Fernández Received Received
  480-OP ANTIVIRAL TREATMENT PATTERNS FOR CYTOMEGALOVIRUS PREVENTION AMONG ADULT KIDNEY TRANSPLANT RECIPIENTS: A USRDS-MEDICARE LINKED DATABASE STUDY Carlos Santos Received Received
  481-OP DONOR CYTOMEGALOVIRUS SEROPOSITIVITY CLUSTERS WITH RISK FACTORS FOR DELAYED GRAFT FUNCTION IN RENAL TRANSPLANTATION, BUT DOES NOT DIRECTLY CONTRIBUTE Richard Dumbill Received Received
  482-OP PREVENTION OF CYTOMEGALOVIRUS INFECTION BY EVEROLIMUS IN SEROPOSITIVE KIDNEY TRANSPLANT RECIPIENTS Lionel Couzi Received Received
  483-OP VALGANCICLOVIR PROPHYLAXIS VERSUS PREEMPTIVE THERAPY FOR PREVENTION OF CYTOMEGALOVIRUS IN RENAL TRANSPLANT RECIPIENTS: A RANDOMIZED CONTROLLED TRIAL Tomas Reischig Received Received
  484-OP INFECTION PATTERN IN EVEROLIMUS VERSUS MYCOPHENOLATE-BASED REGIMENS IN KIDNEY TRANSPLANT RECIPIENTS: 24-MONTH RESULTS FROM THE TRANSFORM STUDY Franco Citterio Received Received
  485-OP OUTCOME OF EBV NEGATIVE RECIPIENTS OF EBV POSITIVE DONOR ORGAN TRANSPLANT IN A SINGLE CENTRE Caroline Dudreuilh Received Received
  486-OP TACROLIMUS METABOLISM RATE AND BK INFECTION IN RENAL TRANSPLANT PATIENTS Dalvir Kular Received Received
  487-OP RELATIONSHIP BETWEEN CARBAPENEM-RESISTANT ENTEROBACTERALES CARRIAGE AND GUT MICROBIOME AFTER LIVER TRANSPLANTATION: A PROSPECTIVE COHORT STUDY Matteo Rinaldi Received Received
  488-OP ASSOCIATION BETWEEN ACUTE GRAFT PYELONEPHRITIS AND KIDNEY GRAFT LOSS: A SINGLE-CENTER OBSERVATIONAL STUDY Mehdi Maanaoui Received Received
  489-OP BACTERIAL AND FUNGAL BLOODSTREAM INFECTIONS IN SOLID ORGAN TRANSPLANT RECIPIENTS: RESULT FROM A DANISH COHORT WITH NATIONWIDE FOLLOW-UP Dina Leth Møller Received Received
  490-OP ENTEROCOCCAL INFECTIONS IN THE FIRST YEAR AFTER LIVER TRANSPLANTATION Daniel Bräuner Rasmussen Received Received
  491-OP SUPERFICIAL SURGICAL SITE INFECTION AT HAND-PORT SITE AFTER HAND ASSISTED LAPAROSCOPIC DONOR NEPHRECTOMY FOR LIVING DONOR KIDNEY TRANSPLANTATION Takahisa Hiramitsu Received Received
  492-OP CONTROLLED DONATION AFTER CIRCULATORY DEATH: IS THERE A RISK FACTOR OF CULTURE-POSITIVE PRESERVATION FLUID ON SOLID ORGANS FOR TRANSPLANTATION? María Figueras Received Received
  493-OP THE "CRITICAL PATHWAY" FOR TISSUE DONATION: NEW DEFINITIONS FOR A COMMON AND SYSTEMATIC EUROPEAN APPROACH TO DECEASED DONOR TISSUE DONATION. Alberto Sandiumenge Received Received
  494-OP HOW DO SPANISH TRANSPLANT COORDINATORS APPROACH RELATIVES FOR CONSENT TO INTENSIVE CARE FOR ORGAN DONATION? RESULTS OF AN EMPIRICAL STUDY Rubén García-Sánchez Received Received
  495-OP ITALIAN SURVEY ON THE OPINIONS OF PROFESSIONALS FROM TRANSPLANT AND INTENSIVE CARE AREAS ABOUT COVID-19 AND SOLID ORGAN TRANSPLANTATION ACTIVITY Federica Galiandro Received Received
  496-OP APPLICATION OF THEORY OF PLANNED BEHAVIOR ON ORGAN DONATION BEHAVIOR: A SYSTEMATIC REVIEW Marzieh Latifi Received Received
  497-OP EUDONORGAN: A SUCCESSFUL TRAINING PROGRAM TO IMPROVE ORGAN DONATION KNOWLEDGE IN THE EUROPEAN UNION AND NEIGHBOURING COUNTRIES. Patricia Peralta Lasso Received Received
  498-OP CONDITIONS THAT INFLUENCE FAMILY CONSENT FOR INTENSIVE CARE FOR ORGAN DONATION: THE PERSPECTIVE OF SPANISH TRANSPLANT COORDINATORS Jorge S. López Received Received
  499-OP ENLIGHTENING YOUNG MINDS: A SMALL STEP IN THE CURRICULUM, A GIANT LEAP IN ORGAN DONATION - A SURVEY OF 996 RESPONDENTS ON ORGAN DONATION Abdul Rahman Hakeem Received Received
  500-OP SEIZING THE POTENTIAL RISK OF TRANSMISSION OF OLIGODENDROGLIOMA TO RECIPIENTS Serena Ammendola Received Received
  501-OP OUT-OF-HOSPITAL DONORS WITH IRREVERSIBLE CARDIAC ARREST IN RUSSIA: ONE OF THE PROMISING RECOURSE ACCORDING THE FIRST ST PETERSBURG EXPERIENCE Andrey Skvortsov Received Received
  502-OP WHAT HAPPENS TO UNSPECIFIED KIDNEY DONOR CANDIDATES WHO CANNOT PROCEED TO DONATE: AN INDUCTIVE THEMATIC ANALYSIS FROM THE BOUND STUDY Mira Zuchowski Received Received
  503-OP DECEASED DONOR TRANSPLANTATION DURING COVID TIMES - SUCCESS STORY FROM STATE IN INDIA. Maria Gomez Received Received
  504-OP NEW TECHNOLOGIES APPLIED TO MASTER EDUCATION IN THE TIME OF COVID-19 Chloe Balleste Received Received
  505-OP IMPACT OF THE SARS-COV-2 PANDEMIC ON TISSUE DONATION IN CATALONIA Belen Garcés Jimeno Received Received
  506-OP EFFECTS OF THE SARS-COV2 PANDEMIC ON ORGAN OFFERS IN EUROPE Federica Domini Received Received
  508-OP A NATIONAL SURVEY ON ENHANCED RECOVERY FOR RENAL TRANSPLANT RECIPIENTS: CURRENT PRACTICES AND TRENDS IN THE UNITED KINGDOM Carrie Scuffell Received Received
  509-OP ENHANCED RECOVERY AFTER SURGERY (ERAS) FOR RENAL TRANSPLANT RECIPIENTS: THE EARLY NEWCASTLE EXPERIENCE Carrie Scuffell Received Received
  510-OP POSITIVE IMPACT OF ERAS PROGRAMME ON LIVING AND DECEASED DONOR RENAL TRANSPLANT RECIPIENTS DURING COVID PANDEMIC Rachel Thomas Received Received
  511-OP FACTORS ASSOCIATED WITH PROLONGED LENGTH OF STAY FOLLOWING RENAL TRANSPLANTATION: A NURSE LED AUDIT Leigh Whinham Received Received
  512-OP PHYSICAL FUNCTION IMPAIRMENT AMONG KIDNEY TRANSPLANT RECIPIENTS AND PATIENTS ON DIALYSIS Wajiha Ghazi Received Received
  514-OP TACROLIMUS MONOTHERAPY IN IMMUNOLOGICALLY LOW-RISK KIDNEY TRANSPLANT RECIPIENTS: A RANDOMIZED-CONTROLLED TRIAL. Annelies De Weerd Received Received
  515-OP COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VS LCPT. Gionata Spagnoletti Received Received
  516-OP OUTCOMES OF IL2-RA INDUCTION THERAPY IN STANDARD-RISK RENAL TRANSPLANT RECIPIENTS MAINTAINED ON TACROLIMUS - A META-ANALYSIS Hatem Ali Received Received
  521-OP GAMMA-DELTA T CELL THERAPY FOR THE TREATMENT OF POST-TRANSPLANT CMV INFECTION: PROOF OF CONCEPT Gabriel Marseres Received Received
  524-OP CHARACTERIZATION OF MESENCHYMAL STEM CELL INDUCED REGULATORY B CELLS (MSC-INDUCED BREG) Sergio G. Garcia Received Received
  700-OP MULTI-OMICS DATA INTEGRATION IN KIDNEY TRANSPLANTATION: THE HIDDEN PATHWAYS OF ANTIBODY-MEDIATED REJECTION Claire Tinel Received Received
  701-OP DEEP PHENOTYPING OF HUMAN KIDNEY TRANSPLANT REJECTION USING SINGLE-CELL TRANSCRIPTOMICS Baptiste Lamarthée Received Received
  713-OP DONATION AFTER CIRCULATORY DEATH (DCD) DONORS IN THE EMILIA-ROMAGNA REGION (ERR): OUR FIRST FORTY CASES Carlo De Cillia Received Received
  716-OP POST-VACCINE IMMUNITY TO COVID-19 VACCINE IN END-STAGE RENAL DISEASE PATIENTS AND KIDNEY TRANSPLANT RECIPIENT Magdalena Piotrowska Received Received
  717-OP ACUTE KIDNEY INJURY AFTER HEART TRANSPLANTATION: ROLE OF INTRAOPERATIVE MANAGEMENT Veronica Moriconi Received Received
  718-OP METABOLIC OUTCOMES AFTER PANCREAS TRANSPLANTATION FROM DONORS AFTER CIRCULATORY DEATH - THE UK REGISTRY ANALYSIS Jeevan Gopal Received Received
  719-OP PORTABLE GAMMA-CAMERA AS A USEFUL TOOL FOR BRAIN DEATH DIAGNOSIS José Moya Sánchez Received Received
  720-OP SPECIFIC URINARY METABOLOMIC PROFILE IN SPONTANEOUS TOLERANT KIDNEY TRANSPLANTED RECIPIENTS Luc Colas Received Received
  721-OP DESIGN OF STEADFAST STUDY EVALUATING TX200-TR101, A CHIMERIC ANTIGEN RECEPTOR T?REGULATORY CELL THERAPY FOR LIVING DONOR RENAL TRANSPLANT RECIPIENTS Emily Culme-Seymour Received Received
  722-OP EARLY SAFETY OF SARS-COV-2 MRNA VACCINES IN SOLID ORGAN TRANSPLANT RECIPIENTS Michael Ou Received Received
  723-OP IDOTCOVID- INTERNATIONAL DATABASE ON ORGAN DONATION AND TRANSPLANTATION - COVID 19 Pedro Ventura-Aguiar Received Received
  724-OP LIMITED IMMUNOGENICITY OF A SINGLE DOSE OF SARS-COV-2 MRNA VACCINE IN SOLID ORGAN TRANSPLANT RECIPIENTS Brian Boyarsky Received Received
  725-OP SARS-COV 2 VACCINATION AND EARLY SPECIFIC IMMUNE RESPONSE IN SOLID ORGAN TRANSPLANT RECIPIENTS Renato Pascale Received Received
  726-OP PROSPECTIVE EVALUATION OF HEALTH-RELATED QUALITY OF LIFE, UNCERTAINTY AND COPING STRATEGIES IN ORGAN TRANSPLANT RECIPIENTS DURING THE COVID PANDEMIC Angus Hann Received Received
  727-OP MOTIVATION, EXPERIENCES, AND MENTAL HEALTH OUTCOMES OF UNSPECIFIED KIDNEY DONORS IN THE NETHERLANDS: A QUALITATIVE STUDY Mathilde Pronk Received Received
  728-OP FIVE YEAR HEPATOCELLULAR CARCINOMA RECURRENCE WITH EVEROLIMUS PLUS REDUCED TACROLIMUS VS STANDARD TACROLIMUS AFTER LIVING-DONOR LIVER TRANSPLANTATION Gonzalo Sapisochin Received Received
  729-OP PREEMPTIVE KIDNEY TRANSPLANTATION VERSUS NON-PREEMPTIVE KIDNEY TRANSPLANTATION IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Reshma Rana Magar Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Cristina Miralles
Hours: Mon-Fri 8:30-15:00
19:49
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

ESOT 2021 Recordings

 

Aug 29 - Sept 1, 2021 Milano
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 29/04/2021 TO 29/08/2022
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert